Article révisé par les pairs
Titre:
  • Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients
Auteur:Awada, Gil; Azambuja, Evandro; Awada, Ahmad
Informations sur la publication:Expert Opinion on Drug Metabolism & Toxicology, 13, 12, page (1205-1215)
Statut de publication:Publié, 2017-12
Sujet CREF:Pharmacologie
Toxicologie pharmaceutique
Mots-clés:angiotensin converting enzyme inhibitor
angiotensin receptor blocker
beta blocker
Cancer
left ventricular dysfunction
prevention
targeted therapy
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1742-5255
info:doi/10.1080/17425255.2017.1398733
info:scp/85036572611
info:pmid/29088977